Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds

  • Simon SilverEmail author
  • Le T. Phung
  • Gregg Silver


Silver products have been used for thousands of years for their beneficial effects, often for hygiene and in more recent years as antimicrobials on wounds from burns, trauma, and diabetic ulcers. Silver sulfadiazine creams (Silvazine and Flamazine) are topical ointments that are marketed globally. In recent years, a range of wound dressings with slow-release Ag compounds have been introduced, including Acticoat, Actisorb Silver, Silverlon, and others. While these are generally accepted as useful for control of bacterial infections (and also against fungi and viruses), key issues remain, including importantly the relative efficacy of different silver products for wound and burn uses and the existence of microbes that are resistant to Ag+. These are beneficial products needing further study, although each has drawbacks. The genes (and proteins) involved in bacterial resistance to Ag have been defined and studied in recent years.


Silver toxicity Medical uses of silver Industrial uses of silver Wound treatments Resistance mechanism 


  1. 1.
    Annear DI, Mee BJ, Bailey M (1976) Instability and linkage of silver resistance, lactose fermentation and colony structure in Enterobacter cloacae. J Clin Path 29:441–443PubMedCrossRefGoogle Scholar
  2. 2.
    Arguello JM (2003) Identification of ion-selectivity determinants in heavy-metal transport P1B-type ATPases. J Membr Biol 195:93–108CrossRefPubMedGoogle Scholar
  3. 3.
    Astashkin AV, Raitsimring AM, Walker FA, Rensing C, McEvoy MM (2005) Characterization of the copper(II) binding site in the pink copper binding protein CusF by electron paramagnetic resonance spectroscopy. J Biol Inorg Chem 10:221–230CrossRefPubMedGoogle Scholar
  4. 4.
    Becker RO (1999) Silver ions in the treatment of local infections. Metal-Based Drugs 6:311–314CrossRefGoogle Scholar
  5. 5.
    Belly RT, Kydd GC (1982) Silver resistance in microorganisms. Dev Indust Microbiol 23:567–577Google Scholar
  6. 6.
    Bragg PD, Rainne DG (1974) The effect of silver ions on the respiratory chain of Escherichia coli. Can J Microbiol 20:883–889PubMedGoogle Scholar
  7. 7.
    Bridges K, Kidson A, Lowbury EJL, Wilkins MD (1979) Gentamicin- and silver-resistant Pseudomonas. Br Med J 1:446–449PubMedCrossRefGoogle Scholar
  8. 8.
    Burrell RE (2003) A scientific perspective on the use of topical silver preparations. Ostomy Wound Manage 49(5A Suppl.):19–24. www.owm.comGoogle Scholar
  9. 9.
    Chu CS, Matylevitch NP, McManus AT, Goodwin CW, Pruitt BA Jr (2000) Accelerated healing with a mesh autograft/allodermal composite skin graft treated with silver nylon dressings with and without direct current in rats. J Trauma 49:115–125PubMedGoogle Scholar
  10. 10.
    Chu CS, McManus AT, Mason AD, Pruitt BA Jr (2005) Topical silver treatment after escharectomy of infected full thickness burn wounds in rats. J Trauma 58:1040–1046PubMedCrossRefGoogle Scholar
  11. 11.
    Chu CS, McManus AT, Matylevich NP, Mason AD Jr, Pruitt BA Jr (1995) Enhanced survival of autoepidermal-allodermal composite grafts in allosensitized animals by use of silver-nylon dressings and direct current. J Trauma 39:273–278PubMedGoogle Scholar
  12. 12.
    Clement JL, Jarrett PS (1994) Antibacterial silver. Metal-Based Drugs 1:467–482CrossRefGoogle Scholar
  13. 13.
    Darouiche RO 1999. Anti-infective efficacy of silver-coated medical prostheses. Clin Infect Dis 29:1371–1377CrossRefPubMedGoogle Scholar
  14. 14.
    Davis IJ, Richards H, Mullany P (2005) Isolation of silver- and antibiotic-resistant Enterobacter cloacae from teeth. Oral Microbiol Immunol 20:191–194CrossRefPubMedGoogle Scholar
  15. 15.
    Deitch EA, Marino AA, Gillespie TE, Albright JA (1983) Silver-nylon: a new antimicrobial agent. Antimicrob Agents Chemother 23:356–359PubMedGoogle Scholar
  16. 16.
    Deitch EA, Marino AA, Malakanok V, Albright JA (1987) Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity. J Trauma 27:301–304PubMedCrossRefGoogle Scholar
  17. 17.
    Dibrov P, Dzioba J, Gosink KK, Hase CC (2002) Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae. Antimicrob Agents Chemother 46:2668–2670CrossRefPubMedGoogle Scholar
  18. 18.
    Dunne SM, Gainsford ID, Wilson NH (1997) Current materials and techniques for direct restorations in posterior teeth. Part 1: silver amalgam. Internat Dental J 47:123–136Google Scholar
  19. 19.
    Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52:662–668CrossRefPubMedGoogle Scholar
  20. 20.
    Franke S, Grass G, Nies DH (2001) The product of the ybdE gene of the Escherichia coli chromosome is involved in detoxification of silver ions. Microbiology 147:965–972PubMedGoogle Scholar
  21. 21.
    Franke S, Grass G, Rensing C, Nies DH (2003) Molecular analysis of the copper-transporting efflux system CusCFBA of Escherichia coli. J Bacteriol 185:3804–3812CrossRefPubMedGoogle Scholar
  22. 22.
    Fraser JF, Bodman J, Sturgess R, Faoagali J, Kimble RM (2004) An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 30:35–41CrossRefPubMedGoogle Scholar
  23. 23.
    Gallant-Behm CL, Yin HQ, Liu S, Heggers JP, Langford RE, Olson ME, Hart DA, Burrell RE (2005) Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. Wound Repair Regen 13:412–421CrossRefPubMedGoogle Scholar
  24. 24.
    George N, Faoagali J, Muller M (1997) Silvazine (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates. Burns 23:493–495CrossRefPubMedGoogle Scholar
  25. 25.
    Gibbs RJ (1999) Silver colloids: do they work? Paperback, published by R. Gibbs, 40 pp, ISBN: 0967699207Google Scholar
  26. 26.
    Gupta A, Maynes M, Silver S (1998) The effects of halides on plasmid silver resistance in Escherichia coli. Appl Environ Microbiol 64:5042–5045PubMedGoogle Scholar
  27. 27.
    Gupta A, Matsui K, Lo JF, Silver S (1999) Molecular basis for resistance to silver cations in Salmonella. Nat Med 5:183–188CrossRefPubMedGoogle Scholar
  28. 28.
    Gupta A, Phung LT, Taylor DE, Silver S (2001) Silver resistance genes in plasmids of the IncHII incompatibility group and on the Escherichia coli chromosome. Microbiology 147:3393–3402PubMedGoogle Scholar
  29. 29.
    Haefeli C, Franklin C, Hardy K (1984) Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J Bacteriol 158:389–392PubMedGoogle Scholar
  30. 30.
    Hendry AT, Stewart IO (1979) Silver-resistant Enterobacteriaceae from hospital patients. Can J Microbiol 25:915–921PubMedGoogle Scholar
  31. 31.
    Holt KB, Bard AJ (2005) Interaction of silver (I) ions with the respiratory chain of Escherichia coli: an electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+. Biochemistry 44:13214–13223CrossRefPubMedGoogle Scholar
  32. 32.
    Innes ME, Umraw N, Fish JS, Gomez M, Cartotto RC (2001) The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns 27:621–627CrossRefPubMedGoogle Scholar
  33. 33.
    Ip M, Lui SL, Poon VKM, Lung I, Burd A (2006) Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 55: 59–63CrossRefPubMedGoogle Scholar
  34. 34.
    Klasen HJ (2000) Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 26:117–130CrossRefPubMedGoogle Scholar
  35. 35.
    Klasen HJ (2000) A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 26:131–138CrossRefPubMedGoogle Scholar
  36. 36.
    Lansdown ABG, Williams A, Chandler S, Benfield S (2005) Silver absorption and antibacterial efficacy of silver dressings. J Wound Care 14:155–160PubMedGoogle Scholar
  37. 37.
    Lansdown ABG (2002) Silver: 1. its antibacterial properties and mechanism of action. J Wound Care 11:125–130PubMedGoogle Scholar
  38. 38.
    Lee SM, Grass G, Rensing C, Barrett SR, Yates CJ, Stoyanov JV, Brown NL (2002) The Pco proteins are involved in periplasmic copper handling in Escherichia coli. Biochem Biophys Res Commun 295:616–620CrossRefPubMedGoogle Scholar
  39. 39.
    Li X-Z, Nikaido H, Williams KE (1997) Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J Bacteriol 179:6127–6132PubMedGoogle Scholar
  40. 40.
    Liu HH (1999) Antibiotic resistance in bacteria: a current and future problem. Adv Exp Med Biol 455:387–396PubMedGoogle Scholar
  41. 41.
    Loftin IR, Franke S, Roberts SA, Weichsel A, Heroux A, Montfort WR, Rensing C, McEvoy MM (2005) A novel copper-binding fold for the periplasmic copper resistance protein CusF. Biochemistry 44:10533–10540CrossRefPubMedGoogle Scholar
  42. 42.
    Lygre GB, Hol PJ, Eide R, Isrenn R, Gjerdet NR (1999) Mercury and silver in saliva from subjects with symptoms self-related to amalgam fillings. Clin Oral Investig 3:216–218CrossRefPubMedGoogle Scholar
  43. 43.
    McHugh SL, Moellering RC, Hopkins CC, Swartz MN (1975) Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet 1: 235–240PubMedGoogle Scholar
  44. 44.
    Melaiye A, Youngs WJ (2005) Silver and its applications as an antimicrobial agent. Expert Opin Ther Pat 15:125–130 Google Scholar
  45. 45.
    Modak SM, Fox CL Jr (1974) Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother 5:582–588PubMedGoogle Scholar
  46. 46.
    Modak SM, Sampath L; Fox CL Jr 1988 Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds. J Burn Care Rehabil 9:359–363PubMedCrossRefGoogle Scholar
  47. 47.
    Monafo WW, West MA (1990) Current treatment recommendations for topical burn therapy. Drugs 40:364–373PubMedCrossRefGoogle Scholar
  48. 48.
    Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW (1998) Burn wound infections: current status. World J Surg 22:135–145CrossRefPubMedGoogle Scholar
  49. 49.
    Richard JW III, Spencer BA, McCoy LF, Carino E, Washington J, Edgar P, Rosenblatt J, Goodheart R, Heggers JP ((2002) Acticoat™ versus Silverlon®: the truth. J Burns 1:11–19Google Scholar
  50. 50.
    Russell AD, Hugo WB (1994) Antimicrobial activity and action of silver. Progress Med Chem 31:351–370CrossRefGoogle Scholar
  51. 51.
    Salyers AA, Amabile-Cuevas CF (1997) Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother 41:2321–2325PubMedGoogle Scholar
  52. 52.
    Silver S (2003) Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27:341–354CrossRefPubMedGoogle Scholar
  53. 53.
    Silver S, Gupta A, Matsui K, Lo JF (1999) Resistance to Ag(I) cations in bacteria: environments, genes and proteins. Metal-Based Drugs 6:315–320CrossRefGoogle Scholar
  54. 54.
    Silver S, Lo J-F, Gupta A (1999) Silver cations as an antimicrobial agent: clinical uses and bacterial resistance. APUA Newslett 17:1–3Google Scholar
  55. 55.
    Silver S, Phung LT (1996) Bacterial heavy metal resistance: new surprises. Annu Rev Microbiol 50:753–789CrossRefPubMedGoogle Scholar
  56. 56.
    Silver S, Phung LT (2005) A bacterial view of the periodic table: genes and proteins for toxic inorganic ions. J Ind Microbiol Biotechnol 32:587–605CrossRefPubMedGoogle Scholar
  57. 57.
    Spadaro JA, Berger TJ, Barranco SD, Chapin SE, Becker RO (1974) Antibacterial effects of silver electrodes with weak direct current. Antimicrob Agents Chemother 6:637–642PubMedGoogle Scholar
  58. 58.
    Thomas S, McCubbin P (2003) A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 12:101–107PubMedGoogle Scholar
  59. 59.
    Vimy MJ, Hooper DE, King WW, Lorscheider FL (1997) Mercury from maternal “silver” tooth fillings in sheep and human breast milk: a source of neonatal exposure. Biol Trace Elem Res 56:143–152PubMedCrossRefGoogle Scholar
  60. 60.
    Yin HQ, Langford R, Burrell RE (1999) Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 20:195–200PubMedCrossRefGoogle Scholar

Copyright information

© Society for Industrial Microbiology 2006

Authors and Affiliations

  1. 1.Department of Microbiology and ImmunologyUniversity of IllinoisChicagoUSA
  2. 2.Argentum Medical LLCWillowbrookUSA

Personalised recommendations